ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah — 1.94M shares

Rhea-AI Filing Summary

ResMed Inc. filed an Amendment No. 2 to a Schedule 13G/A reporting beneficial ownership of 1,943,828 ordinary shares of Nyxoah SA. The filing states this equals 1.95% of Nyxoah's 99,926,284 ordinary shares outstanding as of June 10, 2026. The filing is signed by Aaron Bloomer, Chief Financial Officer.

Insights

Corporate Governance Analyst

ResMed reports a passive sub-5% stake in Nyxoah.

The Schedule 13G/A amendment lists 1,943,828 shares, representing 1.95% of Nyxoah's outstanding shares as of June 10, 2026. The filing is consistent with passive investor disclosure under beneficial-ownership rules.

Because the position is below 5% and labeled "Ownership of 5 Percent or Less of a Class," this appears administrative; subsequent filings would disclose any material change in stake or intent.

Key Figures

Beneficial ownership: 1,943,828 shares Percent of class: 1.95% Shares outstanding (as of): 99,926,284 shares +1 more

4 metrics

Beneficial ownership 1,943,828 shares Amount beneficially owned by ResMed Inc.

Percent of class 1.95% Percent of Nyxoah ordinary shares outstanding

Shares outstanding (as of) 99,926,284 shares Outstanding shares as of <date>June 10, 2026</date>

Filing signature date 07/01/2026 Signed by Aaron Bloomer, CFO

Key Terms

Schedule 13G/A, Beneficially owned, Form 6-K

3 terms

Schedule 13G/A regulatory

"Amendment No. 2 to a Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned regulatory

"Amount beneficially owned: 1,943,828 Ordinary Shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Form 6-K regulatory

"as reported in Exhibit 99.1 to the Issuer's Report of Foreign Private Issuer on Form 6-K"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/01/2026 - 07:00 AM Accepted by SEC EDGAR 07/01/2026 - 07:00 AM Learn about SEC filing dates

FAQ

What stake does ResMed (NYXH) report in Nyxoah SA?

ResMed reports beneficial ownership of 1,943,828 shares of Nyxoah SA. The filing states this equals 1.95% of 99,926,284 outstanding shares as of June 10, 2026.

Does this Schedule 13G/A indicate control or active intent by ResMed?

No; the filing is presented as passive ownership under Schedule 13G/A rules. It also states "Ownership of 5 Percent or Less of a Class," which signals no declared control intent in this amendment.

What is the reference date for the outstanding share count used in the filing?

The outstanding share count is tied to June 10, 2026. The filing cites 99,926,284 Ordinary Shares outstanding as reported in an Exhibit to a Form 6-K filed June 11, 2026.

Who signed the Schedule 13G/A amendment for ResMed?

The amendment is signed by Aaron Bloomer, Chief Financial Officer. The signature block shows the filing date as July 1, 2026.

Will ResMed need to file additional reports if its ownership changes?

Yes; material changes in ownership or intent require updated filings under rule timing. The Schedule 13G/A form and SEC rules prescribe amendments when thresholds or intentions change.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Nyxoah SA

(Name of Issuer)

Ordinary Shares, no nominal value per share

(Title of Class of Securities)

B6S7WD106

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): B6S7WD106

1

Names of Reporting Persons

ResMed Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,943,828.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,943,828.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,943,828.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.95 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Nyxoah SA
(b)	Address of issuer's principal executive offices: Rue Edouard Belin 12 1435 Mont-Saint-Guibert, Belgium
Item 2.
(a)	Name of person filing: This statement is filed by ResMed Inc., a Delaware corporation (the "Reporting Person").
(b)	Address or principal business office or, if none, residence: The address of the business office of the Reporting Person is 9001 Spectrum Center Blvd., San Diego, CA 92123
(c)	Citizenship: Delaware
(d)	Title of class of securities: Ordinary Shares, no nominal value per share
(e)	CUSIP No.: B6S7WD106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,943,828 Ordinary Shares The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 99,926,284 Ordinary Shares outstanding as of June 10, 2026, as reported in Exhibit 99.1 to the Issuer's Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on June 11, 2026.
(b)	Percent of class: 1.95%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,943,828
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 1,943,828
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ResMed Inc.

Signature:	/s/ Aaron Bloomer
Name/Title:	Aaron Bloomer, Chief Financial Officer
Date:	07/01/2026